Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart M Pitson

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Progress in Lipid Research|September 10, 2018
Roles of lysophosphatidic acid and sphingosine-1-phosphate in stem cell biologyGrace E Lidgerwood, Stuart M Pitson, Claudine Bonder, et al.
Reviews in Medical Virology|May 29, 2012
Sphingosine kinase 1 in viral infectionsJillian M Carr, Suresh Mahalingam, Claudine S Bonder, et al.
Cellular & Molecular Biology Letters|February 25, 2009
The effects of markedly raised intracellular sphingosine kinase-1 activity in endothelial cellsVidya Limaye, Mathew A Vadas, Stuart M Pitson, et al.
Cell Death & Disease|June 12, 2024
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemiaGus O Nwosu, David M Ross, Jason A Powell, et al.
Oncotarget|March 3, 2016
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cellsMelissa McNaughton, Melissa Pitman, Stuart M Pitson, et al.
Cell Death Discovery|July 6, 2021
Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
British Journal of Haematology|April 21, 2018
Resistance to proteasome inhibitors and other targeted therapies in myelomaCraig T Wallington-Beddoe, Magdalena Sobieraj-Teague, Bryone J Kuss, et al.
Cell Death Discovery|August 1, 2018
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
The Journal of Biological Chemistry|October 27, 2009
Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1Kate E Jarman, Paul A B Moretti, Julia R Zebol, et al.
Biotechniques|August 9, 2008
Attenuation of leakiness in doxycycline-inducible expression via incorporation of 3' AU-rich mRNA destabilizing elementsDuyen H Pham, Paul A B Moretti, Gregory J Goodall, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Progress in Lipid Research|September 10, 2018
Roles of lysophosphatidic acid and sphingosine-1-phosphate in stem cell biologyGrace E Lidgerwood, Stuart M Pitson, Claudine Bonder, et al.
Reviews in Medical Virology|May 29, 2012
Sphingosine kinase 1 in viral infectionsJillian M Carr, Suresh Mahalingam, Claudine S Bonder, et al.
Cellular & Molecular Biology Letters|February 25, 2009
The effects of markedly raised intracellular sphingosine kinase-1 activity in endothelial cellsVidya Limaye, Mathew A Vadas, Stuart M Pitson, et al.
Cell Death & Disease|June 12, 2024
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemiaGus O Nwosu, David M Ross, Jason A Powell, et al.
Oncotarget|March 3, 2016
Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cellsMelissa McNaughton, Melissa Pitman, Stuart M Pitson, et al.
Cell Death Discovery|July 6, 2021
Author Correction: Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
British Journal of Haematology|April 21, 2018
Resistance to proteasome inhibitors and other targeted therapies in myelomaCraig T Wallington-Beddoe, Magdalena Sobieraj-Teague, Bryone J Kuss, et al.
Cell Death Discovery|August 1, 2018
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignanciesAlexander C Lewis, Craig T Wallington-Beddoe, Jason A Powell, et al.
The Journal of Biological Chemistry|October 27, 2009
Translocation of sphingosine kinase 1 to the plasma membrane is mediated by calcium- and integrin-binding protein 1Kate E Jarman, Paul A B Moretti, Julia R Zebol, et al.
Biotechniques|August 9, 2008
Attenuation of leakiness in doxycycline-inducible expression via incorporation of 3' AU-rich mRNA destabilizing elementsDuyen H Pham, Paul A B Moretti, Gregory J Goodall, et al.
Pageof 15